Aspaveli 1080 mg solution for infusion
*- Company:Swedish Orphan Biovitrum Ltd
- Status:No Recent Update
- Legal Category:Product subject to medical prescription which may not be renewed (A)
- Active Ingredient(s):- This medicinal product is subject to additional monitoring. - *Additional information is available within the SPC or upon request to the company 

 Educational materials 'FOR HEALTHCARE PROFESSIONALS' (HCPs) are additional risk minimisation measures that are intended to promote the safe and effective use of the medicinal product. 
- (Click to Download) - ASPAVELI - Patient Card- Risk Minimisation Materials
- (Click to Download) - A GUIDE TO ASPAVELI® (pegcetacoplan) for patients and caregivers- Risk Minimisation Materials
- (Click to Download) - ASPAVELI - Guide for Healthcare Professionals- Risk Minimisation Materials
Swedish Orphan Biovitrum Ltd

- Address:Suite 2, Riverside 3, Granta Park, Great Abington,, Cambridgeshire, CB21 6AD
- Medical Information E-mail:medical.info.uk@sobi.com
- Telephone:+44 (0) 1223 891854
- Website:https://sobi-uk.co.uk/
- Medical Information Facsimile:+44 (0) 1748 828801
- Medical Information Direct Line:+44 (0) 800 111 4754
- Customer Care direct line:+44 (0) 800 111 4754
